persistence 发表于 2025-3-25 05:03:20

http://reply.papertrans.cn/1/39/3844/3844-21.png

enterprise 发表于 2025-3-25 09:21:23

Submitted on: 20 October 2008.
Revised on: 03 February 2009.
Accepted on: 24 March 2009.

___________________Blood Advances---ELSEVIER

arousal 发表于 2025-3-25 13:20:27

Submitted on: 25 May 2015.
Revised on: 16 August 2015.
Accepted on: 13 October 2015.

___________________Blood Advances---ELSEVIER

Femine 发表于 2025-3-25 16:04:53

Submitted on: 02 March 2018.
Revised on: 08 May 2018.
Accepted on: 28 June 2018.

___________________Blood Advances---ELSEVIER

CLEAR 发表于 2025-3-25 23:16:12

http://reply.papertrans.cn/1/39/3844/3844-25.png

COM 发表于 2025-3-26 04:05:26

Submitted on: 03 March 2024.
Revised on: 24 March 2024.
Accepted on: 11 April 2024.

___________________Blood Advances---ELSEVIER

TAG 发表于 2025-3-26 07:41:47

http://reply.papertrans.cn/1/39/3844/3844-27.png

颂扬国家 发表于 2025-3-26 10:00:50

Submitted on: 24 October 2012.
Revised on: 29 December 2012.
Accepted on: 14 January 2013.

___________________Blood Advances---ELSEVIER

Hla461 发表于 2025-3-26 13:13:16

Submitted on: 29 August 2010.
Revised on: 22 December 2010.
Accepted on: 02 February 2011.

___________________Blood Advances---ELSEVIER

四溢 发表于 2025-3-26 17:54:19

Submitted on: 03 March 2011.
Revised on: 22 June 2011.
Accepted on: 14 August 2011.

___________________Blood Advances---ELSEVIER
页: 1 2 [3] 4
查看完整版本: SCIE期刊Blood Advances 2024/2025影响因子:7.447 (BLOOD ADV) (2473-9529). (HEMATOLOGY)(血液学)Science Citation Index Expanded